21.01.2015 Views

Download Annual Report 2012 - Drees & Sommer

Download Annual Report 2012 - Drees & Sommer

Download Annual Report 2012 - Drees & Sommer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ConstruCtion of new a researCH Center<br />

Laboratories and offices are located behind<br />

the transparent glass facade<br />

Octapharma<br />

creates space<br />

for research &<br />

development in<br />

Heidelberg<br />

The biotechnology specialist completed its new Research Center in Heidelberg on schedule<br />

in October <strong>2012</strong>. Some 50 employees undertake research into recombinant plasma products<br />

in the vicinity of major medical and clinical facilities. <strong>Drees</strong> & <strong>Sommer</strong> life sciences experts<br />

supported the project during the planning and construction phases.<br />

Thanks to its offices in Munich and<br />

Stuttgart, <strong>Drees</strong> & <strong>Sommer</strong> was close<br />

at hand while supporting planning in<br />

Martinsried and the subsequent tender<br />

process and realization in Heidelberg.<br />

This separation of tasks made it possible<br />

for Octapharma to continue to focus<br />

on research, while the project managers<br />

controlled processes on the construction<br />

site. That was particularly important as<br />

the new building was to set the standard<br />

for the company’s future buildings.<br />

plenty of space in the future, too<br />

In future, Heidelberg will not only undertake<br />

innovative research in the field of<br />

recombinant proteins, but also promote<br />

the development and clinical production<br />

of new medicines. A feature of the new<br />

building is a six-meter high room<br />

that can accommodate a 1,000-liter<br />

fermenter for production. It also houses<br />

a laboratory and office facilities for up<br />

to 120 employees. Expansion areas<br />

are primarily located on the third floor,<br />

with GMP-compliant laboratories<br />

taking up most of the first (ground)<br />

and second floors.<br />

<strong>Drees</strong> & <strong>Sommer</strong> impressed clients<br />

with its professional work: In Dessau,<br />

colleagues from the Leipzig office are<br />

already supporting Octapharma’s<br />

next expansion project.<br />

Client<br />

Octapharma Biopharmaceuticals GmbH,<br />

Heidelberg<br />

project duration<br />

January 2010 – October <strong>2012</strong><br />

architects<br />

Burger Architekten und Partner, Heidelberg<br />

Key project data<br />

– GFA: 10,625 m 2<br />

– Cost: € 25 million net<br />

drees & sommer services<br />

– Project control and project management<br />

– Project Communication System (PCS)<br />

value-add achieved for client<br />

– Adherence to budget<br />

– On-schedule consolidation of all employees<br />

at the Heidelberg site<br />

– Technical optimization of construction<br />

processes and use of state-of-the-art<br />

building materials<br />

– Extraction and consolidation of<br />

different locations’ specifications<br />

to establish new standards for this and<br />

future construction projects<br />

Office area<br />

Laboratory area<br />

With some 4,500 employees, Octapharma<br />

has specialized in development, production<br />

and sale of high-quality preparations<br />

derived from human plasma and human<br />

cell lineages. The products help patients<br />

with coagulation disorders and immunodeficiency<br />

in over 80 countries, and<br />

modern intensive care and emergency<br />

medical treatment are unthinkable<br />

without them.<br />

The company now has production<br />

facilities at five sites in Austria, France,<br />

Germany, Sweden and Mexico. Octapharma<br />

Biopharmaceuticals GmbH<br />

was founded in 1997. With premises of<br />

just 1,400 square meters in Martinsried<br />

near Munich, the subsidiary has recorded<br />

a steady growth since its foundation.<br />

new site for further growth<br />

In 2009, production capacity in Martinsried<br />

was too small and urgently needed<br />

space for growth was not available at<br />

the site. For this reason, the company<br />

gravitated towards the Rhine-<br />

Neckar region – a booming center<br />

for the life sciences-industry.<br />

After examining several options,<br />

Octapharma acquired a building<br />

site in the Technology Park in Heidelberg,<br />

Germany. The new location offers<br />

plenty of space and is located close to<br />

prestigious medical and clinical<br />

institutions such as the German Cancer<br />

Research Center and the Heidelberg<br />

University Hospital.<br />

Customer proximity<br />

Thanks to <strong>Drees</strong> & <strong>Sommer</strong>’s many years<br />

of experience with projects in the life<br />

sciences industry, a team of experts<br />

from the company was commissioned<br />

to support the planning and realization<br />

of the 10,000 square meter new building.<br />

The special feature of the project was<br />

that the principal remained completely<br />

operational in Martinsried right up to<br />

the relocation in March <strong>2012</strong>.<br />

Documentation<br />

workplaces<br />

laboratory<br />

Office area<br />

Plan of the second floor of the new building,<br />

(Burger Architekten und Partner, Heidelberg)<br />

44 45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!